Citigroup’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-331,302
| Closed | -$11.6M | – | 5018 |
|
|
2024
Q1 | $11.6M | Buy |
331,302
+286,612
| +641% | +$10M | 0.01% | 834 |
|
|
2023
Q4 | $1.7M | Sell |
44,690
-4,554
| -9% | -$173K | ﹤0.01% | 1769 |
|
|
2023
Q3 | $904K | Buy |
49,244
+1,611
| +3% | +$29.6K | ﹤0.01% | 1990 |
|
|
2023
Q2 | $1.24M | Sell |
47,633
-76,702
| -62% | -$1.99M | ﹤0.01% | 2086 |
|
|
2023
Q1 | $2.35M | Buy |
124,335
+37,822
| +44% | +$714K | ﹤0.01% | 1448 |
|
|
2022
Q4 | $2.13M | Sell |
86,513
-34,948
| -29% | -$861K | ﹤0.01% | 1478 |
|
|
2022
Q3 | $2.18M | Buy |
121,461
+118,361
| +3,818% | +$2.12M | ﹤0.01% | 1545 |
|
|
2022
Q2 | $36K | Sell |
3,100
-13,826
| -82% | -$161K | ﹤0.01% | 4005 |
|
|
2022
Q1 | $377K | Sell |
16,926
-20,179
| -54% | -$449K | ﹤0.01% | 3027 |
|
|
2021
Q4 | $1.62M | Buy |
37,105
+33,723
| +997% | +$1.47M | ﹤0.01% | 2131 |
|
|
2021
Q3 | $113K | Buy |
3,382
+1,879
| +125% | +$62.8K | ﹤0.01% | 3635 |
|
|
2021
Q2 | $41K | Buy |
1,503
+866
| +136% | +$23.6K | ﹤0.01% | 4251 |
|
|
2021
Q1 | $13K | Sell |
637
-995
| -61% | -$20.3K | ﹤0.01% | 4855 |
|
|
2020
Q4 | $54K | Buy |
+1,632
| New | +$54K | ﹤0.01% | 4054 |
|